LifeScience
ANKTIVA Plus BCG Secures European Commission Authorization As First Immunotherapy For BCG Unresponsive NMIBC
ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive blad...
February 20, 2026 | News
Mammotome Introduces In Room MRI Guided Breast Biopsy System To Improve Clinical Workflow
Mammotome, a Danaher company, announces the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed t...
February 19, 2026 | News
Pharmacelera Secures €6 Million To Expand US Footprint And Advance Quantum AI Drug Discovery Platform
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoi...
February 19, 2026 | News
MetaVia Strengthens Global IP Position For DA 1726 With Patent Protection Through 2041
Intellectual Property Portfolio Includes 39 Granted and Pending Patents in the U.S. and Internationally, Providing Protection Into 2041, Unless Extended Fu...
February 17, 2026 | News
Lilac Biosciences And Soin Neuroscience Partner To Advance RNA Based Biomarkers For Pain Research
- Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical too...
February 17, 2026 | News
Jyong Biotech Strengthens Preventive Medicine Position With Positive Phase II Data And Asian Expansion
Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modul...
February 16, 2026 | News
Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong
Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...
February 16, 2026 | News
HanchorBio Secures FDA Orphan Drug Designation For HCB101 In Gastric Cancer
First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...
February 16, 2026 | News
ArkBio Receives FDA IND Clearance For AK3280 Phase Two Trial In Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) applicat...
February 13, 2026 | News
AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
Helix Partners With Mawi DNA To Broaden Access To Non Invasive Genomic Sample Collection
Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expa...
February 12, 2026 | News
Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing
Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...
February 12, 2026 | News
Kirin Holdings And Immunosens Launch Joint Development Of Immune Self Testing Service
Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Ser...
February 11, 2026 | News
Eurofins Viracor BioPharma Expands GLP And GCP Bioanalytical Testing Capabilities
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers...
February 11, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
